ADT Inc. ( NYSE:ADT ), might not be a large cap stock, but it had a relatively subdued couple of weeks in terms ...

As law enforcement and government agencies modernize their IT systems, many are struggling to keep pace with evolving CJIS security mandates. Global research and advisory firm ...

Adt ( ($ADT) ) has provided an update. On October 24, 2025, ADT Inc.’s subsidiaries entered into an amendment to their existing credit agreement, ...

ADT, Inc. engages in the provision of security, automation, and smart home solutions. Its products include security panels, security cameras, ADT mobile application, and identity theft protection. The ...

Background: Cellular indexing of transcriptomes and epitopes by sequencing (CITE-Seq) is a powerful technique to simultaneously measure gene expression and cell surface protein abundances in ...

The anterior drawer test (ADT) has been widely used in assessing mechanical ankle instability (MAI), yet its applicability has been questioned. This study aims to clarify the clinical value of the ADT ...

Video content above is prompted by the following: The rapidly evolving landscape of prostate cancer treatment presents challenges in keeping pace with emerging data and incorporating new combination ...

ADT ($ADT) is expected to release its quarterly earnings data on Thursday, July 24th before market open, per Finnhub. Analysts are expecting revenue of $1,289,158,273 ...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

At a median follow-up of 61.4 months, enzalutamide plus ADT continued to show an improvement in OS vs ADT alone. Initial results from the phase 3 ARCHES trial (NCT02677896) showed an overall survival ...

New analyses from the pivotal Phase III ARANOTE trial in men with metastatic hormone-sensitive prostate cancer (mHSPC) demonstrated an association between more ultra-low prostate-specific androgen ...